An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes

Huanting Chi,Bingqian Qu,Angga Prawira,Talisa Richardt,Lars Maurer,Jungen Hu,Rebecca M Fu,Florian A Lempp,Zhenfeng Zhang,Dirk Grimm,Xianfang Wu,Stephan Urban,Viet Loan Dao Thi
DOI: https://doi.org/10.1038/s44319-024-00236-0
IF: 9.071
2024-09-04
EMBO Reports
Abstract:Abstract Current culture systems available for studying hepatitis D virus (HDV) are suboptimal. In this study, we demonstrate that hepatocyte-like cells (HLCs) derived from human pluripotent stem cells (hPSCs) are fully permissive to HDV infection across various tested genotypes. When co-infected with the helper hepatitis B virus (HBV) or transduced to express the HBV envelope protein HBsAg, HLCs effectively release infectious progeny virions. We also show that HBsAg-expressing HLCs support the extracellular spread of HDV, thus providing a valuable platform for testing available anti-HDV regimens. By challenging the cells along the differentiation with HDV infection, we have identified CD63 as a potential HDV co-entry factor that was rate-limiting for HDV infection in immature hepatocytes. Given their renewable source and the potential to derive hPSCs from individual patients, we propose HLCs as a promising model for investigating HDV biology. Our findings offer new insights into HDV infection and expand the repertoire of research tools available for the development of therapeutic interventions.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?